Reserved
Reserved
Kyverna Therapeutics azioni: +9% in una settimana, ma il ribasso tiene il controllo
EXECUTIVE VIEW
Analisi tecnica delle azioni Kyverna Therapeutics: rimbalzo del 9% sulla media a 20 giorni, volumi in acquisto all'84%, ma il Segnale di Vendita resta in fase di distribuzione alla decima settimana di gestione.
Reserved analysis
Subscribe to read →
Kyverna Therapeutics stock: +9% weekly bounce, but the decline still has control
EXECUTIVE VIEW
Kyverna Therapeutics weekly technical analysis: a 9% bounce off the 20-day average, buy volume up to 84%, but the Sell signal stays in a distribution phase in its 10th week of management.
Reserved analysis
Subscribe to read →